Circadian control of innate immunity in macrophages by miR-155 targeting Bmal1
Anne M Curtis,Caio T Fagundes,Guangrui Yang,Eva M Palsson-McDermott,Paulina Wochal,Anne F McGettrick,Niamh H Foley,James O Early,Lihong Chen,Hanrui Zhang,Chenyi Xue,Sarah S Geiger,Karsten Hokamp,Muredach P Reilly,Andrew N Coogan,Elena Vigorito,Garret A FitzGerald,Luke A J O'Neill
DOI: https://doi.org/10.1073/pnas.1501327112
2015-06-09
Abstract:The response to an innate immune challenge is conditioned by the time of day, but the molecular basis for this remains unclear. In myeloid cells, there is a temporal regulation to induction by lipopolysaccharide (LPS) of the proinflammatory microRNA miR-155 that correlates inversely with levels of BMAL1. BMAL1 in the myeloid lineage inhibits activation of NF-κB and miR-155 induction and protects mice from LPS-induced sepsis. Bmal1 has two miR-155-binding sites in its 3'-UTR, and, in response to LPS, miR-155 binds to these two target sites, leading to suppression of Bmal1 mRNA and protein in mice and humans. miR-155 deletion perturbs circadian function, gives rise to a shorter circadian day, and ablates the circadian effect on cytokine responses to LPS. Thus, the molecular clock controls miR-155 induction that can repress BMAL1 directly. This leads to an innate immune response that is variably responsive to challenges across the circadian day.